| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/21/2004 | US6793927 Isolated pasteurella haemolytica bacterium which comprises a mutation in an aroa gene, wherein the mutation attenuates the bacterium |
| 09/21/2004 | US6793926 Methods for production of a recombinant adeno-associated virus |
| 09/21/2004 | US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells |
| 09/21/2004 | US6793918 Genetic engineering; insertion of adenovirus vectors into cells |
| 09/21/2004 | US6793917 Isolated or purified protein having migration activity on cells expressing ccr4 receptor |
| 09/21/2004 | CA2458085A1 Transcriptional activity assay |
| 09/21/2004 | CA2319587C Method and apparatus for chemical and biochemical reactions using photo-generated reagents |
| 09/21/2004 | CA2195668C Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 09/21/2004 | CA2194032C Fused dna sequence, fused protein expressed from said fused dna sequence and method for expressing said fused protein |
| 09/21/2004 | CA2191182C Oligonucleotide primers for amplifying hcv nucleic acid |
| 09/21/2004 | CA2187629C Novel nucleic acid/polymer complexes, method for preparing same and use thereof for cell transfection |
| 09/21/2004 | CA2156181C Method for obtaining an increased production of a producing celline by using a fusion protocol |
| 09/16/2004 | WO2004079333A2 Method and kit for extracting rna from sputum |
| 09/16/2004 | WO2004079332A2 Composition and method for increasing efficiency of introduction of target substance into cell |
| 09/16/2004 | WO2004079331A2 Composition and method for immobilizing a substance on a solid-phase support |
| 09/16/2004 | WO2004079325A2 Ph dependent signaling dna enzymes |
| 09/16/2004 | WO2004079015A1 Method of detecting escherichia coli and phage for detecting escherichia coli |
| 09/16/2004 | WO2004079009A1 Dna amplification method and kit therefor |
| 09/16/2004 | WO2004079008A1 Screening method for genes of brewing yeast |
| 09/16/2004 | WO2004079000A1 The determination of function of mammalian proteins by analysis of global gene expression profiles |
| 09/16/2004 | WO2004078987A1 A recombinant constructed by a virus vector and a human tumor suppressor gene and its use |
| 09/16/2004 | WO2004078986A1 Infectious flavivirus pseudo-particles containing functional prm and/or e proteins |
| 09/16/2004 | WO2004078985A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/16/2004 | WO2004078984A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/16/2004 | WO2004078983A2 Enhanced amylose production in plants |
| 09/16/2004 | WO2004078982A2 Modified low molecular weight glutenin with reduced risk to patients with celiak disease |
| 09/16/2004 | WO2004078981A1 Hyperactive, non-phosphorylated, mutant transposases of mariner mobile genetic elements |
| 09/16/2004 | WO2004078980A1 Nucleic acid and method of examining canceration using the nucleic acid |
| 09/16/2004 | WO2004078979A1 GLYCOSYLASE GENE SaGT4 AND UTILIZATION THEREOF |
| 09/16/2004 | WO2004078978A1 Compositions and methods for hydroxylating epothilones |
| 09/16/2004 | WO2004078977A1 Subunits of the adenovirus fiber protein and uses thereof as vaccines |
| 09/16/2004 | WO2004078976A1 Vanadium haloperoxidases from the brown alga laminaria digitata and uses thereof |
| 09/16/2004 | WO2004078975A1 Novel protein and use thereof |
| 09/16/2004 | WO2004078974A1 Oligoribonucleotide or peptidic nucleic acid inhibiting function of hepatitis c virus |
| 09/16/2004 | WO2004078972A1 Chimeric receptors and method of screening ligands or inhibitors for the receptors |
| 09/16/2004 | WO2004078971A1 Method of demethylating target methylated region of genomic dna |
| 09/16/2004 | WO2004078966A1 Transgenic plant having fructooligosaccharide accumulated therein and process for constructing the same |
| 09/16/2004 | WO2004078965A1 Process for producing foreign protein in escherichia coli |
| 09/16/2004 | WO2004078962A1 Mobile genetic elements belonging to the mariner family in hydrothermal eukaryotes |
| 09/16/2004 | WO2004078953A1 Translocating enzyme used as a selection marker |
| 09/16/2004 | WO2004078951A1 Process for producing lactonase and utilization thereof |
| 09/16/2004 | WO2004078950A2 METHODS AND COMPOSITIONS FOR SELECTIVE RNAi MEDIATED INHIBITION OF GENE EXPRESSION IN MAMMAL CELLS |
| 09/16/2004 | WO2004078949A2 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 09/16/2004 | WO2004078946A2 Rnai arrays and methods for using the same |
| 09/16/2004 | WO2004078945A2 Nucleotide sequences of 2s albumin gene and its promoter from grape and uses thereof |
| 09/16/2004 | WO2004078941A2 Modulation of gene expression using dna-rna hybrids |
| 09/16/2004 | WO2004078940A2 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1 |
| 09/16/2004 | WO2004078939A2 REGULATION OF Mdm2 FUNCTION |
| 09/16/2004 | WO2004078936A2 Methods for preventing gluconoylation of proteins |
| 09/16/2004 | WO2004078935A2 Removal of plastid sequences by transiently expressed site-specific recombinases |
| 09/16/2004 | WO2004078933A2 Intracellular delivery of small molecules proteins and nucleic acids |
| 09/16/2004 | WO2004078929A2 Materials and methods for identifying genes and/or agents that alter replicative lifespan |
| 09/16/2004 | WO2004078922A2 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 09/16/2004 | WO2004078918A2 Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides |
| 09/16/2004 | WO2004078916A2 In vitro micro-organs, and uses related thereto |
| 09/16/2004 | WO2004078911A2 T-cell transformation by recombinant hvs subgroup c |
| 09/16/2004 | WO2004078909A2 Identification of antigen epitopes |
| 09/16/2004 | WO2004078907A2 Streptococcus pyogenes antigens |
| 09/16/2004 | WO2004078905A2 Agents for phytoremediation |
| 09/16/2004 | WO2004078776A2 Ny-eso-1 peptides which bind to class ii molecules and uses thereof |
| 09/16/2004 | WO2004078713A2 Morpholino based activity mapping |
| 09/16/2004 | WO2004078216A2 Use of a tricyclic antidepressant drug for promoting endocytosis |
| 09/16/2004 | WO2004078181A1 Rna interference based methods and compositions for inhibiting hbv gene expression |
| 09/16/2004 | WO2004078140A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| 09/16/2004 | WO2004078137A2 Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 09/16/2004 | WO2004078135A2 LIGANDS THAT BIND TO THE AMYLOID-β PRECURSOR PEPTIDE AND RELATED MOLECULES AND USES THEREOF |
| 09/16/2004 | WO2004078130A2 Posh interacting proteins and related methods |
| 09/16/2004 | WO2004078124A2 Methods and compositions involving mda-7 |
| 09/16/2004 | WO2004078123A2 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use |
| 09/16/2004 | WO2004078112A2 Apoptosis inducing gene |
| 09/16/2004 | WO2004078097A2 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 09/16/2004 | WO2004077942A2 Inducible prostate cancer model |
| 09/16/2004 | WO2004072225A3 Transgenic fungi expressing bcl-2 and methods of using bcl-2 or portions thereof for improving biomass production, survival, longevity, stress resistance and pathogenicity of fungi |
| 09/16/2004 | WO2004069990A3 Oligomeric compounds for the modulation of thioredoxin expression |
| 09/16/2004 | WO2004069140A3 Antigen imitating extracellular areas of membrane proteins of type iii produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof |
| 09/16/2004 | WO2004067753A3 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof. |
| 09/16/2004 | WO2004065606A3 Glycerol kinase inhibition in transgenic plant cells |
| 09/16/2004 | WO2004065593B1 Recombinant bovine pepsin and pepsinogen produced in prokaryotic and eukaryotic cells |
| 09/16/2004 | WO2004062627A9 In vivo screening models for treatment of alzheimer's disease and other neurodegenerative disorders |
| 09/16/2004 | WO2004062592A3 2-o sulfatase compositions and related methods |
| 09/16/2004 | WO2004058818A3 Spliced variants of lgr6 |
| 09/16/2004 | WO2004056179A9 Genes conferring herbicide resistance |
| 09/16/2004 | WO2004050880B1 Insecticidal agent |
| 09/16/2004 | WO2004050679A3 Mutant glycoproteins |
| 09/16/2004 | WO2004050231A3 (bio) organic oligomers for the preparation of macromolecules |
| 09/16/2004 | WO2004048535A3 Sugar and lipid metabolism regulators in plants v |
| 09/16/2004 | WO2004047731A8 Modulation of notch3 expression |
| 09/16/2004 | WO2004046376A3 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll) |
| 09/16/2004 | WO2004046189A3 Method for generating immunoglobulin genes |
| 09/16/2004 | WO2004046188A3 Anti-activated ras antibodies |
| 09/16/2004 | WO2004046180A3 Chemosensitization by a non-apoptogenic heat shock protein 70-binding apoptosis inducing factor mutant add70 |
| 09/16/2004 | WO2004038021A8 Gpr54 knock-out mammals and screening methods using them |
| 09/16/2004 | WO2004037973A3 Zymomonas pentose-sugar fermentating strains and uses thereof |
| 09/16/2004 | WO2004032973A3 Use of sns insulator of sea urchin for the gene therapy of erythroid cell diseases |
| 09/16/2004 | WO2004030631A3 Anti-cancer and anti-infectious disease compositions and methods for using same |
| 09/16/2004 | WO2004029213A3 Compositions and methods for delivery of short interfering rna and short hairpin rna |
| 09/16/2004 | WO2004026905A3 Transporter/channel proteins |
| 09/16/2004 | WO2004025263A3 Protein and peptide expression for passive immunity |
| 09/16/2004 | WO2004022721A3 Quantification of gene expression |
| 09/16/2004 | WO2004013180A3 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |